Lei Sheng Selected Research

cerous chloride (cerium(III) chloride)

6/2014	Pulmonary toxicity in mice following exposure to cerium chloride.
5/2014	Gene expression profile in chronic mouse liver injury caused by long-term exposure to CeCl3.
5/2013	Hippocampal damage and alterations of inflammatory cytokine expression in mice caused by exposure to cerium chloride.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Sheng Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 05/2016
12	Body Weight (Weight, Body) 01/2022 - 01/2013
12	Inflammation (Inflammations) 01/2022 - 05/2009
8	Breast Neoplasms (Breast Cancer) 10/2021 - 11/2016
8	Wounds and Injuries (Trauma) 11/2020 - 05/2008
6	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2015
6	Necrosis 07/2014 - 01/2013
4	Ischemic Stroke 03/2021 - 01/2016
4	Pneumonia (Pneumonitis) 12/2015 - 10/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
3	Thyroid Nodule (Nodule, Thyroid) 10/2021 - 04/2021
3	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 07/2016
3	Stroke (Strokes) 01/2020 - 08/2014
3	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2019
3	Lung Injury 06/2014 - 10/2012
2	Thrombosis (Thrombus) 01/2022 - 06/2013
2	Rosacea (Acne Rosacea) 01/2022 - 01/2021
2	Ischemia 01/2022 - 11/2017
2	Papillary Thyroid Cancer 04/2021 - 01/2020
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 11/2018
2	Carcinogenesis 11/2018 - 01/2018
2	Neuroinflammatory Diseases 01/2014 - 05/2013
2	Infections 11/2012 - 05/2009
2	Disseminated Intravascular Coagulation 09/2012 - 03/2009
2	Contusions 09/2012 - 05/2008
2	Multiple Trauma (Multiple Injuries) 09/2012 - 05/2008
2	Sepsis (Septicemia) 06/2009 - 05/2008
1	Hypertriglyceridemia 07/2022
1	Atrophy 01/2022
1	Enteritis 01/2022
1	Osteoarthritis 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 01/2022 - 10/2012
10	titanium dioxide (Titania)FDA Link 11/2018 - 10/2012
6	Proteins (Proteins, Gene)FDA Link 12/2018 - 05/2009
5	LipidsIBA 01/2022 - 02/2013
4	EnzymesIBA 01/2022 - 09/2013
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 02/2013
4	TitaniumIBA 02/2015 - 11/2013
3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 11/2012
3	AntioxidantsIBA 06/2014 - 09/2013
3	CeriumIBA 06/2014 - 05/2013
3	cerous chloride (cerium(III) chloride)IBA 06/2014 - 05/2013
3	Dacarbazine (DIC)FDA LinkGeneric 09/2012 - 03/2009
2	Triglycerides (Triacylglycerol)IBA 07/2022 - 01/2022
2	Carvedilol (Coreg)FDA LinkGeneric 01/2022 - 01/2021
2	Toll-Like Receptor 2IBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2016
2	pembrolizumabIBA 01/2022 - 01/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2019
2	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2021 - 11/2017
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2021 - 11/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 05/2009
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 05/2009
2	NivolumabIBA 01/2021 - 01/2021
2	Peptides (Polypeptides)IBA 01/2021 - 12/2017
2	CalciumIBA 07/2020 - 01/2017
2	Vitamin D FDA LinkGeneric 07/2020 - 01/2019
2	ElementsIBA 06/2019 - 02/2013
2	asperphenamateIBA 01/2019 - 12/2018
2	Vitamin D3 24-HydroxylaseIBA 01/2019 - 01/2018
2	CathepsinsIBA 01/2019 - 12/2018
2	Cholecalciferol (Vitamin D3)FDA Link 01/2018 - 11/2016
2	Therapeutic UsesIBA 01/2018 - 09/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017 - 12/2015
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2015 - 06/2014
2	Phosphates (Orthophosphate)IBA 06/2014 - 05/2009
1	eicosapentaenoic acid ethyl esterIBA 07/2022
1	EstersIBA 07/2022
1	Eicosapentaenoic AcidIBA 07/2022
1	SugammadexIBA 01/2022
1	Acarbose FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Proprotein Convertase 9IBA 01/2022
1	GlycosidesIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	itaconic acidIBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Monoterpenes (Monoterpenoids)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	evolocumabIBA 01/2022
1	pinaneIBA 01/2022
1	alirocumabIBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	fibroblast growth factor 21IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022

Therapy/Procedure

6	Therapeutics 01/2022 - 06/2013
4	Drug Therapy (Chemotherapy) 01/2021 - 08/2015
2	Thrombectomy 01/2020 - 01/2020
2	Glycemic Control 01/2016 - 06/2013
2	Intranasal Administration 03/2015 - 02/2014
1	Immunotherapy 01/2022
1	Radiotherapy 01/2022
1	Combined Modality Therapy 01/2022